From Marginal to Central: Marginal Zone‐like B Cells as Critical Targets in Cladribine‐Treated Multiple Sclerosis
Annals of Neurology · 2026
DOI: 10.1002/ana.78277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Marta Pirronello und 20 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimmunology Unit, European Centre for Brain Research, Fondazione Santa Lucia IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Cladribine, Immunosuppressive Agents, Multiple Sclerosis, Relapsing-Remitting, B-Lymphocyte Subsets. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Multiple sclerosis (MS) is a chronic autoimmune disease where B cells play a central pathogenic role. Cladribine, an oral therapy, provides durable benefits by reshaping lymphocyte populations, yet its specific long‐term impact on distinct B‐cell subsets is not fully understood. This study aimed to define cladribine's longitudinal effects on B‐cell subsets and characterize their inflammatory properties.
Methods
We conducted a 48‐month longitudinal study of 36 persons with relapsing–remitting MS treated with cladribine who had completed 2 annual treatment cycles, using high‐parameter flow cytometry to track B‐cell subset dynamics. In a parallel cross‐sectional analysis, B cells from 16 untreated patients and 16 healthy donors were profiled for polyfunctional cytokine production granulocyte‐macrophage colony stimulating factor (GM‐CSF), interleukin‐6 (IL‐6), tumor necrosis factor‐α (TNF‐α) and key surface markers.
Results
Cladribine induced profound, sustained depletion of memory B cells, with marginal zone‐like (MZ‐like) cells showing the deepest and most persistent loss, alongside reconstitution of transitional and naïve populations. Functionally, MZ‐like B cells were the most potent polyfunctional producers of proinflammatory cytokines and immunoglobulin M (IgM), a capacity significantly enhanced in persons with MS compared to healthy donors, and expressed the highest levels of CD1c and CD1d, consistent with specialization in lipid antigen presentation.
Interpretation
MZ‐like B cells are a dominant, polyfunctional inflammatory subset in MS, equipped for non‐canonical lipid antigen presentation and IgM secretion. They represent a preferential pharmacological target of cladribine. Sustained reduction of this pathogenic memory pool, followed by repopulation with less inflammatory B cells, offers a mechanistic basis for cladribine's durable clinical benefit and nominates MZ‐like cells as biomarkers of response and therapeutic targets. ANN NEUROL 2026;100:808–823
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuroimmunology Unit, European Centre for Brain Research, Fondazione Santa Lucia IRCCS, Rome, Italy.
- Department of Internal Medicine and Medical Specialities (DIMI), University of Genova, Genoa, Italy.
- Neuroscience Department, San Camillo-Forlanini Hospital, Rome, Italy.
- Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.
- Neuroimaging Unit, Fondazione Santa Lucia IRCSS, Rome, Italy.
- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy.
ORCID-Profile: Marta Pirronello, Mario Picozza, Gisella Guerrera, Silvia Corbisiero, Andrea Misiti, Roberta C Placido, Alice Verdiani, Lorenzo de Marco, Manolo Sambucci, Elena Olivieri, Daniela F Angelini, Luca Prosperini, Carla Tortorella, Maria C Buscarinu, Valeria Zancan, Marco Salvetti, Claudio Gasperini, Giovanna Borsellino, Luca Battistini
Zitieren
APA
Pirronello, M., Picozza, M., Guerrera, G., Corbisiero, S., Misiti, A., Placido, R. C., Verdiani, A., de Marco, L., Sambucci, M., Olivieri, E., Angelini, D. F., Quartuccio, E., Prosperini, L., Tortorella, C., Buscarinu, M. C., Zancan, V., de Masi, F., Salvetti, M., Gasperini, C., …, & Battistini, L. (2026). From Marginal to Central: Marginal Zone‐like B Cells as Critical Targets in Cladribine‐Treated Multiple Sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.78277
Vancouver
Pirronello M, Picozza M, Guerrera G, Corbisiero S, Misiti A, Placido RC, et al. From Marginal to Central: Marginal Zone‐like B Cells as Critical Targets in Cladribine‐Treated Multiple Sclerosis. Annals of Neurology. 2026. doi:10.1002/ana.78277
BibTeX
@article{Pirronello2026,
author = {Pirronello, Marta and Picozza, Mario and Guerrera, Gisella and Corbisiero, Silvia and Misiti, Andrea and Placido, Roberta C and Verdiani, Alice and de Marco, Lorenzo and Sambucci, Manolo and Olivieri, Elena and Angelini, Daniela F and Quartuccio, Esmeralda and Prosperini, Luca and Tortorella, Carla and Buscarinu, Maria C and Zancan, Valeria and de Masi, Francesca and Salvetti, Marco and Gasperini, Claudio and Borsellino, Giovanna and Battistini, Luca},
title = {From Marginal to Central: Marginal Zone‐like B Cells as Critical Targets in Cladribine‐Treated Multiple Sclerosis},
journal = {Annals of Neurology},
year = {2026},
doi = {10.1002/ana.78277}
}
EUVIMED